26/10/2021 |
VISION Study |
CIGB |
Registered |
14/11/2014 |
Study in Hematological Malignancies |
CIGB |
Registered |
16/02/2017 |
Phase I with CIGB-814 in rheumatoid arthritis patients |
CIGB |
Registered |
23/04/2014 |
CIGB-500 in acute myocardial infarction (AMIGOS study) |
CIGB |
Registered |
10/11/2014 |
CIGB-247-V vaccine in Age-Related Macular Degeneration, phase I-II randomized. |
CIGB |
Registered |
14/04/2020 |
ESPERANZA study |
CIGB |
Registered outdated |
08/04/2015 |
THERESA-5 Study |
CIGB |
Registered |
22/05/2015 |
Safety and pharmacokinetics of CIGB-552 |
CIGB |
Registered |
13/04/2020 |
CIGB 2020 in contacts and SARS-CoV-2 infection suspects |
CIGB |
Registered outdated |
29/10/2021 |
Retrospective observational study of the administration of Jusvinza, for the management of COVID-19 at the Hospital “Dr. Luis Diaz Soto”. |
CIGB |
Registered |
01/02/2016 |
CIGB-370 in patients with malignant tumors |
CIGB |
Registered |
10/11/2021 |
Expanded Clinical Use of Nasalferon in COVID-19 |
CIGB |
Registered outdated |
12/11/2021 |
Nasalferon in COVID-19 |
CIGB |
Registered |
27/05/2016 |
COURAGE Study |
CIGB |
Registered |
05/01/2017 |
HEBERFERON in renal cell carcinoma |
CIGB |
Registered outdated |
30/04/2017 |
CENTAURO-4 Study |
CIGB |
Registered outdated |
26/01/2017 |
ESAR-814 Study |
CIGB |
Registered |
16/02/2017 |
CENTAURO-6 Study |
CIGB |
Registered |
03/05/2020 |
Pharmacodynamics of the Nasalferon in healthy volunteers. |
CIGB |
Registered |
06/08/2020 |
Transfer factor in Chronic Kidney Disease |
CIGB |
Registered outdated |